Simplex Trading, LLC Checkpoint Therapeutics, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
BUY
$0.97 - $1.77 $21,100 - $38,502
21,753 Added 75.31%
50,637 $52,000
Q1 2022

May 02, 2022
SELL
$1.53 - $3.25 $120,236 - $255,404
-78,586 Reduced 73.12%
28,884 $51,000
Q4 2021

Feb 23, 2022
BUY
$2.68 - $4.46 $254,616 - $423,726
95,006 Added 762.24%
107,470 $334,000
Q2 2021

Aug 12, 2021
BUY
$2.36 - $3.2 $24,449 - $33,152
10,360 Added 492.4%
12,464 $36,000
Q1 2021

Apr 26, 2021
BUY
$2.6 - $4.16 $5,470 - $8,752
2,104 New
2,104 $6,000

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $299M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email